Skip to main content
Caplight Logo









QSimulate

QSimulate

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://qsimulate.com/

Last Round

Grant

Mar 13, 2026

Total Funding Raised

$8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

QSimulate is a quantum computing company that develops cloud-based quantitative simulation tools to help the chemical and pharmaceutical industries solve industrial-scale problems.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Quantum Computing, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

computational chemistryquantum computingdrug discoveryquantum simulationmolecular simulationquantum chemistryhybrid quantum-classicalin silico drug discoveryreaction modelingquantum-integrated discoveryphysics-based simulationcomputational drug designquantum-ready workflowsmaterial scienceSaaS platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QSimulate Comparables

Compare QSimulate with similar companies based on industry and business-model similarity.

QSimulate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PolarisQB
85%
Fathom Therapeutics
81%
Molecular Quantum Solutions
81%

QSimulate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 13, 2026
SeedNov 20, 2025
SeedNov 27, 2023
SeedMay 31, 2023
SeedApr 12, 2021

Key People

Founding team and executive leadership

Toru Shiozaki

Co-founder and CEO

Founding Team

Romanos Daniel

Chairman Of The Advisory Board And CFO

Executive Team

Leonie Mueck

Chief Product Officer

Executive Team

QSimulate Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2025

    Seed round led by Embark Ventures.

  • Nov 20, 2025

    Launched QUELO v2.3, the latest generation of its quantum simulation platform.

QSimulate Filings

Explore SEC and related filing metadata, where available.

QSimulate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about QSimulate's valuation, stock price, and market status.

Is QSimulate a public or private company?

QSimulate is a private company.

What is the current stock price of QSimulate?

QSimulate is a private company with no public stock price. No recent secondary market data is available.

How much is QSimulate worth (valuation)?

Valuation information for QSimulate is not publicly available.

Can I buy QSimulate stock?

QSimulate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was QSimulate's last funding round?

QSimulate's most recent funding round was Seed on November 20, 2025.

Who are the main investors in QSimulate?

Key investors in QSimulate include Embark Ventures, 2xN.

Will QSimulate IPO soon?

No public IPO plans have been announced for QSimulate.

How can I track QSimulate secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor QSimulate's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range24
Year Founded2018
Last FundingMar 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?